Last: | $243.17 |
---|---|
Change Percent: | -0.34% |
Open: | $243.1 |
Close: | $243.17 |
High: | $243.7175 |
Low: | $241.24 |
Volume: | 1,025,970 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$243.17 | $243.1 | $243.17 | $243.7175 | $241.24 | 1,025,970 | 07-19-2024 |
$242.27 | $242.63 | $242.27 | $245.09 | $241.45 | 609,218 | 07-18-2024 |
$243.32 | $245 | $243.32 | $245.27 | $242.7 | 653,835 | 07-17-2024 |
$245.19 | $242.39 | $245.19 | $245.37 | $241.88 | 727,648 | 07-16-2024 |
$241.85 | $246.51 | $241.85 | $246.51 | $241.245 | 729,086 | 07-15-2024 |
$246.12 | $245.08 | $246.12 | $246.495 | $244.75 | 745,634 | 07-12-2024 |
$244.5 | $244.43 | $244.5 | $245.77 | $243.18 | 985,343 | 07-11-2024 |
$243.27 | $242.07 | $243.27 | $243.32 | $241.685 | 844,427 | 07-10-2024 |
$242.25 | $242.11 | $242.25 | $243.2 | $241.67 | 982,113 | 07-09-2024 |
$242.88 | $242.39 | $242.88 | $244.39 | $241.4 | 1,548,567 | 07-08-2024 |
$238.19 | $236.43 | $238.19 | $238.41 | $235.57 | 1,349,604 | 07-05-2024 |
$235.85 | $235.94 | $235.85 | $236.88 | $235.2 | 678,162 | 07-04-2024 |
$235.85 | $235.94 | $235.85 | $236.88 | $235.2 | 678,162 | 07-03-2024 |
$235.65 | $235.95 | $235.65 | $237.29 | $234.57 | 922,394 | 07-02-2024 |
$235.5 | $238.96 | $235.5 | $239.49 | $235.13 | 819,697 | 07-01-2024 |
$238 | $238.59 | $238 | $239.89 | $237.79 | 1,806,035 | 06-28-2024 |
$239.55 | $240.5 | $239.55 | $241 | $239.31 | 687,607 | 06-27-2024 |
$240.65 | $240.3 | $240.65 | $241.16 | $239.47 | 712,521 | 06-26-2024 |
$241.18 | $244.25 | $241.18 | $244.62 | $240.5 | 994,755 | 06-25-2024 |
$244.64 | $244.16 | $244.64 | $245.925 | $243.81 | 1,018,210 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
DELRAY BEACH, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- BioProcess360 Partners today announced the launch of a new investment fund to support businesses with the growth of emerging tools and technologies used in the bioprocessing of traditional mAbs and newer drug modalities. BioProcess360 Partners...
Ecolab Inc. (NYSE: ECL) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 2.2% on the day to $243.43. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internatio...
2024-07-08 06:00:05 ET Shlomo Rosenbaum from Stifel Nicolaus issued a price target of $283.00 for ECL on 2024-07-08 05:06:00. The adjusted price target was set to $283.00. At the time of the announcement, ECL was trading at $238.19. The overall price target consensus is ...